Kala Bio, Inc. (KALA)

0.686 -0.08 (-10.90%) USD  |  NASDAQ  |  Dec 11, 16:00
0.6951 +0.01 (+1.33%) After-Hours: 20:00
More

Kala Bio Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for KALA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
Q32 Bio, Inc. Upgrade
PharmaCyte Biotech, Inc. Upgrade
Allogene Therapeutics, Inc. Upgrade
Akero Therapeutics, Inc. Upgrade
Belite Bio, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade